These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12027077)

  • 1. Hypersensitivity syndrome associated with dapsone/pyrimethamine (Maloprim) antimalaria chemoprophylaxis.
    Thong BY; Leong KP; Chng HH
    Ann Allergy Asthma Immunol; 2002 May; 88(5):527-9. PubMed ID: 12027077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapsone hypersensitivity syndrome masquerading as a viral exanthem: three cases and a mini-review.
    Tee AK; Oh HM; Wee IY; Khoo BP; Poh WT
    Ann Acad Med Singap; 2004 May; 33(3):375-8. PubMed ID: 15175785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agranulocytosis during malaria prophylaxis with Maloprim (pyrimethamine and dapsone).
    Booth F; Barker LC; Barton CJ; Naik RB
    Postgrad Med J; 1984 Aug; 60(706):566-7. PubMed ID: 6473241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprophylaxis of malaria in Africa.
    Rée GH
    Br Med J (Clin Res Ed); 1983 Feb; 286(6364):562. PubMed ID: 6402151
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study of Lapudrine (chlorproguanil) and Maloprim (pyrimethamine and dapsone) as chemoprophylactics against malaria in Gambian children.
    Greenwood BM; Greenwood AM; Smith AW; Menon A; Bradley AK; Snow RW; Sisay F; Bennett S; Watkins WM; N'Jie AB
    Trans R Soc Trop Med Hyg; 1989; 83(2):182-8. PubMed ID: 2692227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed drug eruptions to maloprim.
    Tham SN; Chan HL
    Singapore Med J; 1988 Jun; 29(3):300-2. PubMed ID: 2973126
    [No Abstract]   [Full Text] [Related]  

  • 7. Malaria prophylaxis with doxycycline in soldiers deployed to the Thai-Kampuchean border.
    Watanasook C; Singharaj P; Suriyamongkol V; Karwacki JJ; Shanks D; Phintuyothin P; Pilungkasa S; Wasuwat P
    Southeast Asian J Trop Med Public Health; 1989 Mar; 20(1):61-4. PubMed ID: 2772704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maloprim for malaria prophylaxis.
    Donovan KD
    Med J Aust; 1985 Sep; 143(7):319-20. PubMed ID: 4046929
    [No Abstract]   [Full Text] [Related]  

  • 9. ELISA tests for dapsone and pyrimethamine and their application in a malaria chemoprophylaxis programme.
    Greenwood BM; Greenwood AM; Bradley AK; Shenton FC; Smith AW; Snow RW; Williams K; Eggelte TA; Huikeshoven H; de Wit M
    Bull World Health Organ; 1986; 64(6):909-16. PubMed ID: 3493860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprophylaxis against malaria in Papua New Guinea: a trial of amodiaquine and a combination of dapsone and pyrimethamine.
    Vrbova H; Gibney S; Gibson FD; Jolley D; Heywood PF; Stace J; Trenholme KR; Alpers MP
    P N G Med J; 1992 Dec; 35(4):275-84. PubMed ID: 1341089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe dapsone syndrome due to weekly maloprim.
    Grayson ML; Yung AP; Doherty RR
    Lancet; 1988 Mar; 1(8584):531. PubMed ID: 2893942
    [No Abstract]   [Full Text] [Related]  

  • 12. Agranulocytosis associated with malaria prophylaxis with Maloprim.
    Friman G; Nyström-Rosander C; Jonsell G; Björkman A; Lekås G; Svendsrup B
    Br Med J (Clin Res Ed); 1983 Apr; 286(6373):1244-5. PubMed ID: 6404407
    [No Abstract]   [Full Text] [Related]  

  • 13. Malaria prophylaxis prescribed for travellers from New Zealand.
    Leggat PA; Heydon JL; Menon A
    N Z Med J; 1997 Aug; 110(1050):319-21. PubMed ID: 9315032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperpigmented dermal macules in children following the administration of Maloprim for malaria chemoprophylaxis.
    David KP; Marbiah NT; Lovgren P; Greenwood BM; Petersen E
    Trans R Soc Trop Med Hyg; 1997; 91(2):204-8. PubMed ID: 9196770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agranulocytosis associated with maloprim: review of cases.
    Hutchinson DB; Whiteman PD; Farquhar JA
    Hum Toxicol; 1986 Jul; 5(4):221-7. PubMed ID: 3733111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maloprim--general toxicity or idiosyncrasy?
    Vergara RV
    P N G Med J; 1984 Mar; 27(1):46. PubMed ID: 6595907
    [No Abstract]   [Full Text] [Related]  

  • 17. Proguanil/sulfamethoxazole malaria chemoprophy-laxis on the Thai-Cambodian border.
    Karwacki JJ; Shanks GD; Suriyamongkol V; Watanasook C
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):77-80. PubMed ID: 1948264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maloprim-induced pulmonary eosinophilia.
    Begbie S; Burgess KR
    Chest; 1993 Jan; 103(1):305-6. PubMed ID: 8417912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dapsone induced cholangitis as a part of dapsone syndrome: a case report.
    Itha S; Kumar A; Dhingra S; Choudhuri G
    BMC Gastroenterol; 2003 Aug; 3():21. PubMed ID: 12911838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of acute non-specific upper respiratory tract infections in healthy men taking dapsone-pyrimethamine for prophylaxis against malaria.
    Lee PS; Lau EY
    Br Med J (Clin Res Ed); 1988 Mar; 296(6626):893-5. PubMed ID: 3129063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.